Non-functional adrenal tumors were associated with an increased risk for psychiatric and sleep disorders, especially for younger patients.
News Medical on MSN
ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients
A multicenter Phase II clinical trial led by researchers at The University of Texas MD Anderson Cancer Center demonstrated significant tumor shrinkage and disease control in patients with advanced ...
Researchers sought to determine the prevalence of heart failure with concurrent adrenal insufficiency, as well as related clinical outcomes and health care utilization.
MedPage Today on MSN
New Drug for Rare Neuroendocrine Tumors Shows Durable Activity
BERLIN -- Belzutifan (Welireg) induced durable responses in advanced pheochromocytoma or paraganglioma (PPGL) in a single-arm ...
Support cells in the adrenal gland can regenerate hormone-producing tissue after birth and may act as a starting point for adrenal tumors.
Feeling fear is an evolutionary survival tactic. A small number of people have a rare condition that means they're not scared ...
A new pill called baxdrostat may offer hope for people whose blood pressure stays high even after taking standard medications ...
Rates of transient ischemic attack, mitral valve stenosis, and heart failure declined after parathyroidectomy among patients ...
Neurocrine Biosciences shows strong growth with rising INGREZZA sales, expanding pipeline, and solid financials despite key ...
The American Heart Association has published a scientific statement regarding post-myocardial infarction psychological distress.
The combination of Lenvima (lenvatinib) and Keytruda (pembrolizumab) with chemotherapy did not help patients with metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results